a Therapeutics(COYA) - 2024 Q2 - Quarterly Results
a Therapeutics(US:COYA)2024-08-12 12:04Coya Therapeutics Provides a Corporate Update and Reports Unaudited Second Quarter 2024 Financial Results Houston, TX, August 12, 2024 -- Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a corporate update and announces its financial results for the quarter ended June 30, 2024. Recent Corporate Highlights • Presented updated biomarker data in late April 2024 at the 2 n ...